Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
DIMERIX LIMITED (DXB)ASX AI Signals has generated 1 signal(s) for DXB during the last 90 days, indicating Moderate trading activity
Latest DXB Signals | |
| 29/04/2026 | SELL |
| 31/03/2026 | SELL |
DXB Share Price | |
| Current Price | $0.240 |
| 52 Week High | $0.625 |
| 52 Week Low: | $0.165 |
| Trading at (% of 52 Week High) | 38.40% |
Dimerix Limited (ASX: DXB) is a clinical-stage biotechnology company focused on developing therapies for chronic diseases with high unmet medical needs. The company’s lead asset, DMX-200, targets kidney and lung diseases through innovative drug delivery approaches. Dimerix aims to improve patient outcomes by advancing its novel therapeutic solutions.
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
The SELL recommendation for DIMERIX LIMITED (DXB) is supported by bearish technical signals and weak recent performance indicators, suggesting downside risk. However, moderate market volatility and sector-specific factors introduce some uncertainty.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Everest Medicines has signed an exclusive licensing agreement with Dimerix to develop and commercialize DMX-200 across Asia-Pacific. The deal focuses on treating serious kidney diLatest DIMERIX LIMITED(DXB) News
Everest Medicines (SEHK:1952) Signs Dimerix Deal For DMX 200 In Asia Pacific
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial